Author
Navarre Institute of Health ResearchORCID 0000-0003-0503-7905Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Stefany Infante, Eva Santa María, Alexander Finnemore…·Josepmaria Argemí
This study identifies ATF4 as a key driver of immune evasion in β-catenin-driven hepatocellular carcinoma by programming a proline-dependent metabolic axis that suppresses anti-tumor immunity.
Elena Adán-Villaescusa, Borja Castelló-Uribe, Iker Uriarte…·Maite G Fernandez-Barrena
This study shows that inhibiting G9a enhances the effectiveness of immune checkpoint inhibitors in hepatocellular carcinoma by improving tumor immunogenicity and T cell infiltration.
Marta E. Camarena, Patrick Theunissen, Marta Ruiz…·M. Mar Albà
The paper identifies non-canonical ORFs as a significant source of tumor-specific antigens in liver cancer, showing they can trigger immune responses and are shared among a substantial proportion of patients.